Loading...
Market
Which company will first license QuantumScale for commercial use by end of 2024?
2
Resolution / Starting Odds
Illumina • 25%
Thermo Fisher Scientific • 25%
Roche • 25%
Other • 25%
Official announcements from Scale Biosciences or the licensing company
Story
Scale Biosciences Unveils $277M '100 Million Cell Challenge' with QuantumScale Technology
Aug 14, 2024, 01:56 PM
Scale Biosciences has launched a significant initiative in the field of single-cell genomics with the introduction of the '100 Million Cell Challenge'. This program, in collaboration with Ultima Genomics and NVIDIA, aims to advance research by providing substantially subsidized costs for library preparation and sequencing. Selected projects will gain early access to Scale Bio's QuantumScale, a cutting-edge single-cell RNA sequencing technology capable of processing 2 million cells per run. The initiative includes a grant program designed to support groundbreaking research in genomics. With $277 Million in new funding, the first 50M cells accepted will be highly subsidized.
View original story
Similar markets
Microsoft • 25%
IBM • 25%
Google • 25%
Other • 25%
Google • 25%
IBM • 25%
Microsoft • 25%
Other • 25%
IBM • 25%
Google • 25%
Microsoft • 25%
Other • 25%
IBM • 25%
Microsoft • 25%
Amazon • 25%
Other • 25%
IBM • 25%
Google • 25%
Microsoft • 25%
Other • 25%
IBM • 25%
Microsoft • 25%
Amazon • 25%
Other • 25%
IBM • 25%
Microsoft • 25%
Amazon • 25%
Other • 25%
Google • 25%
IBM • 25%
Microsoft • 25%
Other • 25%
Google • 25%
IBM • 25%
Microsoft • 25%
Other • 25%
IBM • 25%
Google • 25%
Microsoft • 25%
Other • 25%
Nvidia • 25%
Google • 25%
A joint announcement by Nvidia and Google • 25%
Another company • 25%
Microsoft • 33%
Google • 33%
Atom Computing • 33%